INVESTMENT (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| ILiAD Biotechnologies, LLC [Member] | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | ||
| Book value of the investment | $ 6,849,000 | $ 6,849,000 | ||
| Iliad [Member] | Class C Units [Member] | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Ownership percentage not fully diluted | 6.50% | 6.50% | ||
| Iliad [Member] | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | ||
| Equity investment net loss | $ 308,000 | $ 532,000 | $ 1,613,000 | $ 1,597,000 |
| Iliad [Member] | Class C Units [Member] | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Ownership percentage fully diluted | 4.90% | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|